ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Arsenic in a cup: new oral formula could change leukemia treatment
Disease control CompletedThis study looked at an oral arsenic solution (SDK001) in 12 people with acute promyelocytic leukemia (APL). Researchers wanted to see how the body processes the oral drug compared to the standard IV version, and whether food or calcium supplements affect absorption. The goal is …
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 11:00 UTC
-
AI boosts rare cancer diagnosis speed and accuracy
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated May 26, 2026 11:10 UTC